Seroma, Hematoma Seroma, Hematoma, Inguinal hernia, Laparoscopic inguinal hernia repair, Tranexamic Acid, Topical, Hernia surgery, Laparoscopy
Conditions
Interventions
Standard laparoscopic inguinal hernia surgery plus additional topical tranexamic acid 250mg/5ml per side at pseudosac after hernia sac reduction. For example patient with bilateral inguinal hernia wil
Experimental Procedure/Surgery,Active Comparator Procedure/Surgery
Topical TXA,Standard
Sponsors
VENERABLE THAWISAK JUTINDHARO HOSPITAL
Eligibility
Sex/Gender
Male
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patient who was diagnosed inguinal hernia and underwent laparoscopic inguinal hernia surgery
Exclusion criteria
Exclusion criteria: 1. Contraindication for Tranexamic acid 1.1 Subarachnoid hemorrhage 1.2 Cerebral infarction 1.3 Venous thrombosis 1.4 Seizure 1.5 Renal failure 2. Allergic to Tranexamic acid 3. Complicated inguinal hernia that require emergency surgery (for example incarcerated hernia, strangulated hernia) 4. Fail to surgery with laparoscopic technique
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Seroma 2,6 weeks clinical (yes/no), ultrasonography (width*length*depth calculate in ml) | — |
Secondary
| Measure | Time frame |
|---|---|
| Hematoma 2,6 weeks clinical (yes/no), ultrasonography (width*length*depth calculate in ml),Recurrence 2,6 weeks Clinical (yes/no),SSI 2,6 weeks Clinical (yes/no),TXA adverse effect 2,6 weeks Clinical (yes/no) | — |
Countries
Thailand
Contacts
Public ContactPICHET WATTANAPREECHANON
VENERABLE THAWISAK JUTINDHARO HOSPITAL
Outcome results
None listed